BOSTON, MA--(Marketwired - October 13, 2016) - The 11th Annual Cardiometabolic Health Congress successfully concluded at the Sheraton Boston after hosting over a thousand healthcare professionals, featuring 5 headlining Keynotes and 40+ world-renowned speakers from October 5-8. Topics highly relevant to today's healthcare such as Nutritional Interventions for Clinicians and Practice Management Issues related to capital and leadership skills were covered in new workshops. The Exhibit Hall showcased technological innovations, products, and prevention tools which offered attendees the opportunity to network along with the ability to meet esteemed faculty in the "Meet the Experts" booth.
The Keynote by Dr. Steven Nissen kicked off the CMHC and offered insight into how intravascular ultrasound has helped establish which therapies ultimately slow or regress the progression of coronary atherosclerosis. Other meeting highlights include Dr. Clyde Yancy's explanation of how the SPRINT results reinforce the connection between hypertension and heart failure, Dr. Jay Skyler's update on diabetes clinical trials which described the impact of short-term, intensive intervention, as well as the differences between three CV outcome trials; and finally, Dr. Caroline Apovian's presentation illustrating how consistency and early treatment are both key in obesity interventions.
"Some of the greatest benefits of the CMHC are the latest updates on all aspects of the treatment of patients with multiple cardiometabolic risk factors," Christie M. Ballantyne, MD, CMHC co-chair and Professor of Medicine, Baylor College of Medicine, said. "The most exciting aspect of the conference this year was the presentations on clinical trials for new therapies for diabetes that showed that treatment of high-risk patients reduced CVD events. There are tremendous advances every year in the treatment of lipids, obesity, hypertension, diabetes, thrombosis, heart failure, and kidney disease."
Robert H. Eckel, MD, also a CMHC co-chair and Professor of Medicine and Charles A. Boettcher Chair in Atherosclerosis at the University of Colorado, Aschutz Medical Campus, said, "The Venn diagram of metabolic disorders and cardiovascular disease continues to close and the CMHC does a tremendous job defining how this relationship is changing. Every year presentations by thought leaders in the field of cardiometabolic health impact attendees on how their day-to-day decision making can be updated by advances that have taken place. This conference is a must for HCPs who want to remain on the cutting edge of meeting their patients' needs in this very important cardiometabolic space."
The Cardiometabolic Health Congress has grown to be the largest US-based, multidisciplinary conference addressing cardiometabolic disease prevention and its interdependencies through an integrated approach to education. With more than one-third of the population having at least one cardiometabolic risk factor -- dyslipidemia, CHD, hypertension, diabetes, and/or obesity -- the CMHC provides a one-of-a-kind opportunity for busy clinicians to catch up on the latest developments in these overlapping areas of cardiometabolic health.
Visit the Cardiometabolic Health Congress website at www.cardiometabolichealth.org, for more information on CMHC live conferences, a free online CME-CE library, news, and clinician resources.